Researchers


A large-scale clinical study from The National Cancer Institute (NCI) demonstrated that x-ray CT screening sharply reduced lung cancer deaths by detecting cancers at relatively early stages. Patients screened with x-ray CT were 20% less likely to die from lung cancer. Annual screening by x-ray CT detects lung cancers in their earliest stage, when survival is most promising. However, the study also showed that low-dose CT scans tend to have a high false positive rate.

A major milestone for lung cancer, the Centers for Medicare and Medicaid approved reimbursing low-dose CT scans in a high-risk group of patients (ages 55-77 who have smoked one pack of cigarettes a day for 30 years) in February 2015.

About LuCED®

LuCED does not use radiation. Rather, it uses a sputum sample that can be collected through spontaneous coughs over a three-day period using a take-home test kit. LuCED kits are shipped to the VisionGate Biosignatures Laboratory (VBL) and then samples are processed on our proprietary Cell-CT technology, a component of LuCED. The first automated 3D cell imaging platform, this revolutionary technology computes sub-micron resolution biosignatures from intact cells. Cell classifiers then automatically identify abnormal cells in sputum. Please view the Cost-Effectiveness study conducted by the University of Arizona.

VisionGate currently has collaborations or pending IRBs with:

NYU Langone Cancer CenterKaiser Permanente
Fred Hutchinson Cancer Research CenterSwedish Cancer Institute
Memorial Sloan KetteringToronto General Hospital
Cancer Treatment Centers of AmericaDignity Health
Oregon Health & Science UniversityUniversity of Navarra (Spain)
Aristotle University (Greece)

To discuss opportunities, please contact VisionGate at 602.354.8862 or send an email to info@visiongate3d.com.


Related Pages

Notify Me When It Arrives

Complete the fields below to be notified when our LuCED® Lung Cancer Test becomes available.

Your Name (required)

Your Email (required)

Your State (required)

Contact Us

If you are interested in learning more about the VisionGate® Cell-CT™ technology and would like to speak with someone, please complete this short inquiry form and a VisionGate representative will contact you as soon as possible.


Copyright 2017 - VisionGate, Inc.